Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: Recent Advances and Future Directions in Translational Research
Author:
- 2 May 2022
- journal article
- editorial
- Published by Springer Nature in Translational Stroke Research
- Vol. 14 (2) , 119-120
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysisNeurosurgical Focus, 2022
- Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A ReviewJournal of the American Heart Association, 2021
- Tenecteplase Thrombolysis for Acute Ischemic StrokeStroke, 2020
- Aneurysmal Subarachnoid Hemorrhage: the Last DecadeTranslational Stroke Research, 2020
- Comparative analysis of fibrinolytic properties of Alteplase, Tenecteplase and Urokinase in an in vitro clot model of intracerebral haemorrhageJournal of Stroke and Cerebrovascular Diseases, 2020
- Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid HemorrhageStroke, 2020
- Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trialThe Lancet Neurology, 2014
- Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trialThe Lancet, 2012
- Randomized Trial of Clazosentan in Patients With Aneurysmal Subarachnoid Hemorrhage Undergoing Endovascular CoilingStroke, 2012
- Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)The Lancet Neurology, 2011